Friday, May 03, 2024

Events | 2018.10.03

Seqirus Presents Favorable Outcomes Data for Adjuvanted Trivalent Influenza Vaccine (FLUAD®) at 6th Annual IDWeek

SAN FRANCISCO, Oct. 3, 2018 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, will present new healthcare and cost outcomes data for its MF59®-adjuvanted trivalent influenza vaccine (FLUAD) at IDWeek in San Francisco (October 5-6). Results from five different studies...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]h-annual-idweek-300724074.html

You need to login to post comments.

Feed last updated 2024/05/31 @5:05 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News